UTRECHT, March 26, 2025 – Single Cell Discoveries, a leading Contract Research Organization (CRO) specializing in single-cell and spatial transcriptomics, is proud to announce its accreditation as the first European Certified Service Provider of BioSkryb Genomics’ ResolveServices. This milestone marks Single Cell Discoveries’ strategic expansion of its single-cell toolkit.
Through this partnership, Single Cell Discoveries will provide advanced single-cell multi-omic analysis in fields such as oncology, cell & gene therapy, immunology, reproductive genetics, toxicology, and neurology, addressing a wide range of complex biological questions.
Providing the most comprehensive view of the genome and transcriptome
As a Certified Service Provider, Single Cell Discoveries now offers BioSkryb Genomics’ state-of-the-art ResolveServices, which leverage innovative technologies such as ResolveDNA® and ResolveOME™. These solutions enable comprehensive, high-quality multi-omic analysis:
- ResolveDNA® utilizes Primary Template-directed Amplification (PTA) to deliver near-complete genomic coverage, providing reliable and reproducible whole-genome amplification (WGA) in low-input samples and single cells.
- ResolveOME™ combines PTA-based WGA with full-transcript reverse transcription, allowing for simultaneous analysis of both the genome and transcriptome within a single cell. This integrated approach provides researchers with critical insights into the impact of genomic variations on gene expression.
By integrating these cutting-edge technologies into its service portfolio, Single Cell Discoveries empowers researchers to explore cellular heterogeneity, molecular dynamics, and disease progression with unprecedented precision. The protocols are designed to fit seamlessly together, offering a complementary and cohesive toolkit that supports researchers in tackling complex biological questions across the entire single-cell workflow.
Dr. Sabine Tanis, Team Lead of R&D at Single Cell Discoveries, says,” We are very excited to add this technology to our portfolio, unlocking deeper insights into single-cell data and advancing our clients’ understanding of molecular mechanisms in disease.”
The Single Cell Discoveries team was recently certified by Dr. Katie Kennedy, Study Director of ResolveServices, who says, “This is a fantastic opportunity that puts the power of our technology into the hands of a group that is as deeply quality- and empowerment-minded as we are. European researchers can now rely on consistent, high-quality biological insights, without the need to ship their samples overseas.”
About Single Cell Discoveries
Founded in 2018 by Mauro Muraro, PhD, and Judith Vivié, MSc, Single Cell Discoveries is a leading CRO specializing in single-cell sequencing. The company partners with biopharmaceutical organizations, healthcare institutions, and academic research centers worldwide to deliver high-quality transcriptomic insights. Headquartered in Utrecht, the Netherlands, Single Cell Discoveries continues to drive innovation in the field of single-cell and spatial transcriptomics.
For more information, visit www.scdiscoveries.com and follow Single Cell Discoveries on LinkedIn and Twitter.
About BioSkryb Genomics
BioSkryb Genomics is a rapidly growing organization that is transforming single-cell molecular discovery and analysis. Through its single-cell whole genome and transcriptome amplification tools and services, scientists and clinicians can gain an unprecedented view of the genome, transcriptome, and targeted proteins from each single cell to better understand the drivers and mechanisms of those diseases, which they aim to translate into the improved management of complex diseases. The company is headquartered in Durham, North Carolina. For more information, visit bioskryb.com.
This official press release may be freely copied and distributed by digital and traditional media platforms.
Header photo shows the ResolveDNA and ResolveOME kits being used in the lab.